68 results
Page 2 of 4
8-K
yntpsio6s8o1uz1an
9 Aug 22
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
6:45am
8-K
EX-1.1
ix9ax i3twynt7mo3qkt
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
k7r7mczzwlps pncrt
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
55t luegt
20 Jul 22
Prospectus supplement for primary offering
4:22pm
S-3
p5mwgv
1 Jul 22
Shelf registration
4:36pm
8-K
avkq0gm
13 Jun 22
Departure of Directors or Certain Officers
4:34pm
DEF 14A
i4au88
29 Apr 22
Definitive proxy
7:01am
10-K
fl4k2e3eh
14 Mar 22
Annual report
7:04am
10-K
EX-10.5
1jif 14tsrkvef
14 Mar 22
Annual report
7:04am
10-K
EX-10.19
ez5b6e2ztmqz2bvenap
14 Mar 22
Annual report
7:04am
10-K
EX-10.4
rpavo5nhkot bda1o98
14 Mar 22
Annual report
7:04am
10-Q
u1srpvirx
12 Aug 21
Quarterly report
8:53am
8-K
EX-3.2
5ievj3bas
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
8-K
EX-3.1
h6mzmax ghvi3r692i
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm
424B4
vqwr0q0d362bzqfuo1
17 Jun 21
Prospectus supplement with pricing info
4:50pm